Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma

IMPORTANCE: Identifying which patients with COVID-19 are likely to benefit from COVID-19 convalescent plasma (CCP) treatment may have a large public health impact. OBJECTIVE: To develop an index for predicting the expected relative treatment benefit from CCP compared with treatment without CCP for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyung, Tarpey, Thaddeus, Liu, Mengling, Goldfeld, Keith, Wu, Yinxiang, Wu, Danni, Li, Yi, Zhang, Jinchun, Ganguly, Dipyaman, Ray, Yogiraj, Paul, Shekhar Ranjan, Bhattacharya, Prasun, Belov, Artur, Huang, Yin, Villa, Carlos, Forshee, Richard, Verdun, Nicole C., Yoon, Hyun ah, Agarwal, Anup, Simonovich, Ventura Alejandro, Scibona, Paula, Burgos Pratx, Leandro, Belloso, Waldo, Avendaño-Solá, Cristina, Bar, Katharine J, Duarte, Rafael F., Hsue, Priscilla Y., Luetkemeyer, Anne F., Meyfroidt, Geert, Nicola, André M., Mukherjee, Aparna, Ortigoza, Mila B., Pirofski, Liise-anne, Rijnders, Bart J. A., Troxel, Andrea, Antman, Elliott M., Petkova, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790670/
https://www.ncbi.nlm.nih.gov/pubmed/35076698
http://dx.doi.org/10.1001/jamanetworkopen.2021.47375

Ejemplares similares

Ejemplares similares